In a cohort of patients with severe and complicated obesity completing a milk-based meal replacement programme with substantial weight loss over 24 weeks, we found a significant, early and unanticipated rise in ALT that was particularly pronounced in patients who had an elevated ALT at the start of the intervention. The gene discussed is GPT; the disease is obesity disorder.